Compare · all pairs
A
NAD+
B
Tirzepatide
A side-by-side look at what NAD+ and Tirzepatide actually are, so you can see where they overlap and where they genuinely differ before deciding which is worth researching further — no score, no “winner,” just the facts next to each other.
FDA status
NAD+
No FDA-approved product exists in any form
Tirzepatide
FDA-approved — Zepbound & Mounjaro (the compounded version this board ranks is not independently FDA-reviewed)
Typical dose / use
NAD+
No standard dose — sold as injectable, nasal spray, or oral liquid, mostly subscription-priced
Tirzepatide
2.5–15 mg/week (FDA label range)
Product forms
NAD+
Injectable, nasal spray, or oral liquid
Tirzepatide
Injectable
How it works
NAD+
A coenzyme central to cellular energy metabolism and DNA repair; a 2026 systematic review of 113 studies found zero eligible outcome trials for injectable/IV NAD+ itself, versus a real but mixed 28-trial literature for oral precursors.
Tirzepatide
Activates two hormone receptors at once — GIP and GLP-1 — slowing gastric emptying, increasing insulin release when blood sugar is high, and reducing appetite.
Providers ranked on this board
NAD+
39
Tirzepatide
111
Cost on this board
NAD+
From $84/mo
Tirzepatide
From $79/mo
Every fact above is reused from NAD+'s and Tirzepatide's own compound guides, not re-derived here. A highlighted value means that number is objectively larger or smaller — more providers ranked, a lower standing price — never a claim about which compound is “better.” Cost and provider counts are read live from each compound's own board and can change without notice.
Go deeper on each compound
NAD+
Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.
This page is a fact comparison, not a recommendation for either compound — talk to a licensed clinician about your own situation.